Literature DB >> 29802541

The Exosome-Derived Biomarker in Atherosclerosis and Its Clinical Application.

Mengmeng Lu1, Shuaifang Yuan1, Shicheng Li2, Ling Li1, Min Liu3,4, Shaogui Wan5,6.   

Abstract

Exosomes are now accepted as potential biomarkers in cardiovascular disease development, especially in atherosclerosis. Atherosclerosis is a leading cause of cardiovascular disease-related death and morbidity, accounting for one-fifth of all deaths globally. Therefore, the biomarkers for the management of atherosclerosis is urgently needed. Exosomes are reported to play key roles cell-to-cell communication in atherosclerosis with lipid bilayer membranous vesicles containing nucleic acids, proteins, and lipid contents, which are released from all most of multiple kinds of living cells. This review aims to discuss the potential roles of exosome-derived miRNA, protein, and DNA as biomarkers in atherosclerosis pathogenesis, diagnosis, and therapy.

Entities:  

Keywords:  Atherosclerosis; Biomarkers; Cardiovascular disease; Exosomes; miRNA

Mesh：

Substances：

Year:  2018        PMID： 29802541     DOI： 10.1007/s12265-018-9796-y

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN： 1937-5387            Impact factor:   4.132


  37 in total

1.  MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis.

Authors:  Song Gao; Michael Wassler; Lulu Zhang; Yangxin Li; Jun Wang; Yi Zhang; Harnath Shelat; Jason Williams; Yong-Jian Geng
Journal:  Atherosclerosis       Date:  2013-11-19       Impact factor: 5.162

2.  Identification of miRNAs as atherosclerosis biomarkers and functional role of miR-126 in atherosclerosis progression through MAPK signalling pathway.

Authors:  X-Z Hao; H-M Fan
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

Review 3.  Extracellular vesicles as new pharmacological targets to treat atherosclerosis.

Authors:  Min Yin; Xavier Loyer; Chantal M Boulanger
Journal:  Eur J Pharmacol       Date:  2015-07-02       Impact factor: 4.432

4.  The nature and significance of platelet products in human plasma.

Authors:  P Wolf
Journal:  Br J Haematol       Date:  1967-05       Impact factor: 6.998

5.  Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease.

Authors:  Edward J Goetzl; Janice B Schwartz; Maja Mustapic; Iryna V Lobach; Richard Daneman; Erin L Abner; Gregory A Jicha
Journal:  FASEB J       Date:  2017-05-05       Impact factor: 5.191

Review 6.  Exosomes and exosomal miRNAs in cardiovascular protection and repair.

Authors:  Costanza Emanueli; Andrew I U Shearn; Gianni D Angelini; Susmita Sahoo
Journal:  Vascul Pharmacol       Date:  2015-04-11       Impact factor: 5.773

7.  Association of plasma miR-223 and platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy: A preliminary report.

Authors:  Bernadeta Chyrchel; Justyna Totoń-Żurańska; Olga Kruszelnicka; Michał Chyrchel; Waldemar Mielecki; Maria Kołton-Wróż; Paweł Wołkow; Andrzej Surdacki
Journal:  Platelets       Date:  2014-10-28       Impact factor: 3.862

8.  Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.

Authors:  Eduard Hergenreider; Susanne Heydt; Karine Tréguer; Thomas Boettger; Anton J G Horrevoets; Andreas M Zeiher; Margot P Scheffer; Achilleas S Frangakis; Xiaoke Yin; Manuel Mayr; Thomas Braun; Carmen Urbich; Reinier A Boon; Stefanie Dimmeler
Journal:  Nat Cell Biol       Date:  2012-02-12       Impact factor: 28.824

9.  MiRNAs as biomarkers of myocardial infarction: a meta-analysis.

Authors:  Chao Cheng; Qiang Wang; Wenjie You; Manhua Chen; Jiahong Xia
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

Review 10.  Exosomal miRNAs as potential biomarkers of cardiovascular risk in children.

Authors:  Abdelnaby Khalyfa; David Gozal
Journal:  J Transl Med       Date:  2014-06-10       Impact factor: 5.531
View more
  39 in total

1.  Exosomes in Cardiovascular Diseases and Treatment: Experimental and Clinical Aspects.

Authors:  Jing Wang; Chenglin Zhao; Junjie Xiao
Journal:  J Cardiovasc Transl Res       Date:  2019-01-07       Impact factor: 4.132

Review 2.  New Insights into the Role of Exosomes in the Heart After Myocardial Infarction.

Authors:  Na Li; Luc Rochette; Yongxin Wu; Nathalie Rosenblatt-Velin
Journal:  J Cardiovasc Transl Res       Date:  2018-09-02       Impact factor: 4.132

3.  Exosome-Derived MiRNAs as Biomarkers of the Development and Progression of Intracranial Aneurysms.

Authors:  Bao Liao; Meng-Xiao Zhou; Feng-Kun Zhou; Xiu-Mei Luo; Song-Xin Zhong; Yuan-Fang Zhou; Yan-Sheng Qin; Ping-Ping Li; Chao Qin
Journal:  J Atheroscler Thromb       Date:  2019-10-10       Impact factor: 4.928

4.  CD14 and CD26 from serum exosomes are associated with type 2 diabetes, exosomal Cystatin C and CD14 are associated with metabolic syndrome and atherogenic index of plasma.

Authors:  Claudia Paola Pérez-Macedonio; Eugenia Flores-Alfaro; Luz Del C Alarcón-Romero; Amalia Vences-Velázquez; Natividad Castro-Alarcón; Eduardo Martínez-Martínez; Monica Ramirez
Journal:  PeerJ       Date:  2022-07-12       Impact factor: 3.061

5.  Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes for Angiogenesis.

Authors:  Chengwei Ju; Youngjun Li; Yan Shen; Yutao Liu; Jingwen Cai; Naifeng Liu; Gengshan Ma; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-10-01       Impact factor: 4.132

Review 6.  The Exosome: a New Player in Diabetic Cardiomyopathy.

Authors:  Lichan Tao; Jia Shi; Xiaoyu Yang; Ling Yang; Fei Hua
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

7.  Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium.

Authors:  Chengwei Ju; Yan Shen; Gengshan Ma; Yutao Liu; Jingwen Cai; Il-Man Kim; Neal L Weintraub; Naifeng Liu; Yaoliang Tang
Journal:  J Cardiovasc Transl Res       Date:  2018-09-19       Impact factor: 4.132

Review 8.  Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications.

Authors:  Nicoleta Alexandru; Anastasia Procopciuc; Alexandra Vîlcu; Ioana Karla Comariţa; Elisabeta Bӑdilӑ; Adriana Georgescu
Journal:  Rev Endocr Metab Disord       Date:  2021-06-18       Impact factor: 6.514

Review 9.  Extracellular Vesicles: Versatile Nanomediators, Potential Biomarkers and Therapeutic Agents in Atherosclerosis and COVID-19-Related Thrombosis.

Authors:  Adriana Georgescu; Maya Simionescu
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

Review 10.  The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

Authors:  Lee Ohayon; Xinyi Zhang; Partha Dutta
Journal:  Pharmacol Res       Date:  2021-06-25       Impact factor: 10.334
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.